Publications
21
Citations
568
Est. group size
~8
Recurring co-author estimate
Active years
11
Publishing since 2014
Typically publishes in teams of ~7 · 10% small-team papers (≤3 authors) · across 8 venues
- Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis
JCI Insight · 2021
- Notch3: A New Culprit in Fibrotic Lung Disease
American Journal of Respiratory Cell and Molecular Biology · 2021
- SOX9 Is a Positive Regulator of Fibroblast Activation in Idiopathic Pulmonary Fibrosis
2021
- Fibrocyte accumulation in the lungs of cystic fibrosis patients
Journal of Cystic Fibrosis · 2020
- Aberrant Upregulation of SOX9 by Distal Lung Mesenchymal Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
2020
- Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach
Journal of Molecular Medicine · 2019
- New therapeutics based on emerging concepts in pulmonary fibrosis
Expert Opinion on Therapeutic Targets · 2018
- Disposition and clinical implications of protein-bound uremic toxins
Clinical Science · 2017
- Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma
Hypertension · 2017
- SP045A PROTEO-BIOSTATISTIC APPROACH FOR FINDING THE UNDERLYING MOLECULAR DETERMINANTS OF HYPERTENSION
Nephrology Dialysis Transplantation · 2017
- JCI Insight×1
- Nature Genetics×1
- Clinical Science×1
- Expert Opinion on Therapeutic Targets×1
- International Journal of Molecular Sciences×1
- Jazmín Calyeca
Medicine · The Ohio State University
- Mauricio Rojas
Medicine · The Ohio State University
- Elizabeth A. Mickler
Medicine · Indiana University
- Sem H. Phan
Medicine · University of Michigan
- Steven K. Huang
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile